Fig. 4From: Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticlesDetected plasma α-synuclein concentrations using IMR for healthy subjects, PD patients and PDD patientsBack to article page